SENTIA: an intensive medicines monitoring programme for proactive safety surveillance of neuroleptic treatment in children and adolescents

被引：0
|
作者：
Palanca Maresca, Inmaculada [1 ]
Ruiz-Antoran, Belen [2 ]
Olza-Fernandez, Ibone [1 ]
Siles, Ana [3 ]
Villagra, Sandra [3 ]
Fernandez Rivas, Aranzazu [4 ]
Garcia Vega, Juan Manuel [1 ]
Centeno, Gustavo [2 ]
Roman, Enriqueta [5 ]
Avendano-Sola, Cristina [2 ]
机构：
[1] Univ Puerta de Hierro, Majadahonda Hosp, Child & Adolescent Psychiat Unit, Madrid, Spain
[2] Univ Puerta de Hierro, Majadahonda Hosp, Dept Clin Pharmacol, Madrid, Spain
[3] Univ Puerta de Hierro, Majadahonda Hosp, Paediat Cardiol Unit, Madrid, Spain
[4] Basurto Hosp, Child & Adolescent Psychiat Unit, Bilbao, Spain
[5] Univ Puerta de Hierro, Majadahonda Hosp, Paediat Serv, Madrid, Spain
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2013年 / 22卷
关键词：
Antipsychotic; adverse effects; pharmacovigilance registry; paediatric populations;
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
PS-046
引用
收藏
页码：S230 / S231
页数：2
相关论文
共 50 条
  • [11] SENTIA: ONLINE REGISTRY OF SAFETY IN ANTIPSYCHOTIC TREATMENT IN CHILDREN AND ADOLESCENTS. A MULTICENTRE PROJECT FOR A LONG-TERM OPEN PROSPECTIVE STUDY
    Ruiz-Antoran, B.
    Palanca-Maresca, M.
    Cabrera-Garcia, L.
    Sancho-Lopez, A.
    Centeno-Soto, G. A.
    Avendano-Sola, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 35 - 35
  • [12] INTENSIVE SECURE TREATMENT FOR CHILDREN AND ADOLESCENTS
    ZASLAW, GD
    CHILD WELFARE, 1977, 56 (08) : 529 - 536
  • [13] Monitoring success of a weight reduction programme in children and adolescents
    Winklhofer-Roob, B. M.
    Fasching, U.
    Pamperl, I.
    Huetter, E.
    Kandlbauer, M.
    Edelbrunner, G.
    Gutsche, B.
    Schifferl, C.
    Weber, R.
    Stocklin, E.
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 362 - 362
  • [14] Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme
    Hill, Geraldine R.
    Ashton, Janelle
    Harrison-Woolrych, Mira
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1217 - 1226
  • [15] Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme
    Hill, Geraldine R.
    Harrison-Woolrych, Mira
    NEW ZEALAND MEDICAL JOURNAL, 2008, 121 (1283) : 68 - 74
  • [16] Intensive Treatment of Specific Phobias in Children and Adolescents
    Davis, Thompson E., III
    Ollendick, Thomas H.
    Ost, Lars-Goran
    COGNITIVE AND BEHAVIORAL PRACTICE, 2009, 16 (03) : 294 - 303
  • [17] Evaluation of an intensive stuttering treatment for children and adolescents
    Metten, C.
    Zueckner, H.
    Rosenberger, S.
    SPRACHE-STIMME-GEHOR, 2007, 31 (02): : 72 - 78
  • [18] Signal generation in the New Zealand Intensive Medicines Monitoring Programme - A combined clinical and statistical approach
    Coulter, DM
    DRUG SAFETY, 2002, 25 (06) : 433 - 439
  • [19] A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP).
    Clark, DWJ
    Beggs, PW
    Williams, SM
    Coulter, DM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R473 - R473
  • [20] A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP)
    Beggs, PW
    Clark, DWJ
    Williams, SM
    Coulter, DM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (01) : 99 - 104
12345